Skip to main content
Log in

Poisoning Through Pediatric Skin: Cases from the Literature

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Poisoning through pediatric skin leading to acute systemic symptoms is a relatively uncommonly reported phenomenon. Systemic toxicity through the skin typically occurs by direct contact between therapeutic or non-therapeutic topical agents and the skin. Though uncommon, poisoning through pediatric skin can have significant consequences and must be recognized so the offending agent may be discontinued and appropriate treatment initiated. We performed a literature search for all article types between 1950 and April 2016 to provide a single source of detectable cases of acute toxicity in pediatric patients due to percutaneous exposure. This literature review discusses relevant pediatric skin physiology along with reports of poisoning events that resulted in systemic signs and symptoms and even death to provide a comprehensive report on causes of pediatric poisoning through the skin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gimenez ER, Vallejo NE, Izurieta EM, Roy E, Rossi SM, Lis M, et al. Acute alcoholic intoxication by the percutaneous route. Clinical and experimental study. Arch Argent Pediatr. 1968;66(4):121–35.

    CAS  PubMed  Google Scholar 

  2. Castot A, Garnier R, Lanfranchi C, Bavoux F. Systemic side effects of drugs applied cutaneously: report of a few cases in infants (author’s transl). Therapie. 1980;35(3):423–32.

    CAS  PubMed  Google Scholar 

  3. Harpin V, Rutter N. Percutaneous alcohol absorption and skin necrosis in a preterm infant. Arch Dis Child. 1982;57(6):477–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Puschel K. Percutaneous alcohol intoxication. Eur J Pediatr. 1981;136(3):317–8.

    Article  CAS  PubMed  Google Scholar 

  5. Garrison RF. Acute poisoning from use of isopropyl alcohol in tepid sponging. J Am Med Assoc. 1953;152(4):317–8.

    Article  CAS  PubMed  Google Scholar 

  6. Senz EH, Goldfarb DL. Coma in a child following use of isopropyl alcohol in sponging. J Pediatr. 1958;53(3):322–3.

    Article  CAS  PubMed  Google Scholar 

  7. McFadden SW, Haddow JE. Coma produced by topical application of isopropanol. Pediatrics. 1969;43(4):622–3.

    CAS  PubMed  Google Scholar 

  8. Dyer S, Mycyk MB, Ahrens WR, Zell-Kanter M. Hemorrhagic gastritis from topical isopropanol exposure. Ann Pharmacother. 2002;36(11):1733–5.

    Article  PubMed  Google Scholar 

  9. Vivier PM, Lewander WJ, Martin HF, Linakis JG. Isopropyl alcohol intoxication in a neonate through chronic dermal exposure: a complication of a culturally-based umbilical care practice. Pediatr Emerg Care. 1994;10(2):91–3.

    Article  CAS  PubMed  Google Scholar 

  10. Kahn A, Blum D. Methyl alcohol poisoning in an 8-month-old boy: an unusual route of intoxication. J Pediatr. 1979;94(5):841–3.

    Article  CAS  PubMed  Google Scholar 

  11. Lundell E, Nordman R. A case of infantile poisoning by topical application of Castellani’s solution. Ann Clin Res. 1973;5(6):404–6.

    CAS  PubMed  Google Scholar 

  12. Rogers SC, Burrows D, Neill D. Percutaneous absorption of phenol and methyl alcohol in Magenta Paint B.P.C. Br J Dermatol. 1978;98(5):559–60.

    Article  CAS  PubMed  Google Scholar 

  13. Von Hinkel G, Kitzell H. Phenolvergiftungen bei Neugeborenen durch kutane Resorption. Dtsch Gesundh-Wes. 1968;23:240.

    Google Scholar 

  14. Unlu RE, Alagoz MS, Uysal AC, Orbay H, Kilinc H, Tekin F, et al. Phenol intoxication in a child. J Craniofac Surg. 2004;15(6):1010–3.

    Article  PubMed  Google Scholar 

  15. Department of Health and Human Services Agency for Toxic Substances and Disease Registry. Medical management guidelines for phenol. http://www.atsdr.cdc.gov/MHMI/mmg115.pdf. Accessed 23 June 2016.

  16. Haggerty RJ. Hazards to health: blue baby due to methemoglobinemia. N Engl J Med. 1962;267:1303.

    Article  CAS  Google Scholar 

  17. Eldadah M, Fitzgerald M. Methemoglobinemia due to skin application of benzocaine. Clin Pediatr (Phila). 1993;32(11):687–8.

    Article  CAS  PubMed  Google Scholar 

  18. Wolff JA. Clinical conference: methemoglobinemia due to benzocaine. Pediatrics. 1957;20(5 Part 1):915–6.

  19. Tush GM, Kuhn RJ. Methemoglobinemia induced by an over-the-counter medication. Ann Pharmacother. 1996;30(11):1251–4.

    Article  CAS  PubMed  Google Scholar 

  20. Rincon E, Baker RL, Iglesias AJ, Duarte AM. CNS toxicity after topical application of EMLA cream on a toddler with molluscum contagiosum. Pediatr Emerg Care. 2000;16(4):252–4.

    Article  CAS  PubMed  Google Scholar 

  21. Touma S, Jackson JB. Lidocaine and prilocaine toxicity in a patient receiving treatment for mollusca contagiosa. J Am Acad Dermatol. 2001;44(2 Suppl):399–400.

    Article  CAS  PubMed  Google Scholar 

  22. Raso SM, Fernandez JB, Beobide EA, Landaluce AF. Methemoglobinemia and CNS toxicity after topical application of EMLA to a 4-year-old girl with molluscum contagiosum. Pediatr Dermatol. 2006;23(6):592–3.

    Article  PubMed  Google Scholar 

  23. Parker JF, Vats A, Bauer G. EMLA toxicity after application for allergy skin testing. Pediatrics. 2004;113(2):410–1.

    Article  PubMed  Google Scholar 

  24. Larson A, Stidham T, Banerji S, Kaufman J. Seizures and methemoglobinemia in an infant after excessive EMLA application. Pediatr Emerg Care. 2013;29(3):377–9.

    Article  PubMed  Google Scholar 

  25. Shachor-Meyouhas Y, Galbraith R, Shavit I. Application of topical analgesia in triage: a potential for harm. J Emerg Med. 2008;35(1):39–41.

    Article  PubMed  Google Scholar 

  26. Sinisterra S, Miravet E, Alfonso I, Soliz A, Papazian O. Methemoglobinemia in an infant receiving nitric oxide after the use of eutectic mixture of local anesthetic. J Pediatr. 2002;141(2):285–6.

    Article  PubMed  Google Scholar 

  27. Wehner D, Hamilton GC. Seizures following topical application of local anesthetics to burn patients. Ann Emerg Med. 1984;13(6):456–8.

    Article  CAS  PubMed  Google Scholar 

  28. Maulidi H, McNair C, Seller N, Kirsh J, Bradley TJ, Greenway SC, et al. Arrhythmia associated with tetracaine in an extremely low birth weight premature infant. Pediatrics. 2012;130(6):e1704–7.

    Article  PubMed  Google Scholar 

  29. Ohlgisser M, Adler M, Ben-Dov D, Taitelman U, Birkhan HJ, Bursztein S. Methaemoglobinaemia induced by mafenide acetate in children. A report of two cases. Br J Anaesth. 1978;50(3):299–301.

    Article  CAS  PubMed  Google Scholar 

  30. Herd JK, Cramer A, Hoak FC, Norcross BM. Ototoxicity of topical neomycin augmented by dimethyl sulfoxide. Pediatrics. 1967;40(5):905–7.

    CAS  PubMed  Google Scholar 

  31. Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma. 2006;60(3):648–52.

    Article  PubMed  Google Scholar 

  32. Fligner CL, Jack R, Twiggs GA, Raisys VA. Hyperosmolality induced by propylene glycol. A complication of silver sulfadiazine therapy. JAMA. 1985;253(11):1606–9.

    Article  CAS  PubMed  Google Scholar 

  33. Viala J, Simon L, Le Pommelet C, Philippon L, Devictor D, Huault G. Agranulocytosis after application of silver sulfadiazine in a 2-month old infant. Arch Pediatr. 1997;4(11):1103–6.

    Article  CAS  PubMed  Google Scholar 

  34. Ternberg J, Luce E. Methemoglobinemia: a complication of the silver nitrate treatment of burns. Surgery. 1968;63:328–30.

    Google Scholar 

  35. Chan CY, Wallander KA. Diphenhydramine toxicity in three children with varicella-zoster infection. DICP. 1991;25(2):130–2.

    CAS  PubMed  Google Scholar 

  36. Huston RL, Cypcar D, Cheng GS, Foulds DM. Toxicity from topical administration of diphenhydramine in children. Clin Pediatr (Phila). 1990;29(9):542–5.

    Article  CAS  PubMed  Google Scholar 

  37. Reilly JF Jr, Weisse ME. Topically induced diphenhydramine toxicity. J Emerg Med. 1990;8(1):59–61.

    Article  PubMed  Google Scholar 

  38. Filloux F. Toxic encephalopathy caused by topically applied diphenhydramine. J Pediatr. 1986;108(6):1018–20.

    Article  CAS  PubMed  Google Scholar 

  39. Bernhardt DT. Topical diphenhydramine toxicity. Wis Med J. 1991;90(8):469–71.

    CAS  PubMed  Google Scholar 

  40. Patranella P. Diphenhydramine toxicity due to topical application of Caladryl. Clin Pediatr. 1986;25:163.

    Google Scholar 

  41. Turner JW. Death of a child from topical diphenhydramine. Am J Forensic Med Pathol. 2009;30(4):380–1.

    Article  PubMed  Google Scholar 

  42. Zell-Kanter M, Toerne TS, Spiegel K, Negrusz A. Doxepin toxicity in a child following topical administration. Ann Pharmacother. 2000;34(3):328–9.

    Article  CAS  PubMed  Google Scholar 

  43. Vo MY, Williamsen AR, Wasserman GS. Toxic reaction from topically applied doxepin in a child with eczema. Arch Dermatol. 1995;131(12):1467–8.

    Article  CAS  PubMed  Google Scholar 

  44. Shawn DH, McGuigan MA. Poisoning from dermal absorption of promethazine. Can Med Assoc J. 1984;130(11):1460–1.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Agin H, Calkavur S, Uzun H, Bak M. Amitraz poisoning: clinical and laboratory findings. Indian Pediatr. 2004;41(5):482–6.

    PubMed  Google Scholar 

  46. Atabek ME, Aydin K, Erkul I. Different clinical features of amitraz poisoning in children. Hum Exp Toxicol. 2002;21(1):13–6.

    Article  CAS  PubMed  Google Scholar 

  47. Aydin K, Kurtoglu S, Poyrazoglu MH, Uzum K, Ustunbas HB, Hallac IK. Amitraz poisoning in children: clinical and laboratory findings of eight cases. Hum Exp Toxicol. 1997;16(11):680–2.

    Article  CAS  PubMed  Google Scholar 

  48. Kalyoncu M, Dilber E, Okten A. Amitraz intoxication in children in the rural Black Sea region: analysis of forty-three patients. Hum Exp Toxicol. 2002;21(5):269–72.

    Article  CAS  PubMed  Google Scholar 

  49. US Food and Drug Administration. Lindane lotion USP, 1% [label]. http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/006309lotionlbl.pdf. Accessed 23 June 2016.

  50. Mathis L. Memorandum. Postmarket Drug Safety Information for Patients and Providers. http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM110853.pdf. Accessed 23 June 2016.

  51. Lee B, Groth P. Scabies: transcutaneous poisoning during treatment. Pediatrics. 1977;59(4):643.

    CAS  PubMed  Google Scholar 

  52. Bhalla M, Thami GP. Reversible neurotoxicity after an overdose of topical lindane in an infant. Pediatr Dermatol. 2004;21(5):597–9.

    Article  PubMed  Google Scholar 

  53. Davies JE, Dedhia HV, Morgade C, Barquet A, Maibach HI. Lindane poisonings. Arch Dermatol. 1983;119(2):142–4.

    Article  CAS  PubMed  Google Scholar 

  54. Berry DH, Brewster MA, Watson R, Neuberg RW. Untoward effects associated with lindane abuse. Am J Dis Child. 1987;141(2):125–6.

    CAS  PubMed  Google Scholar 

  55. Daud Y, Daud ur R, Farooq U. Lindane toxicity in a 7 year old boy. J Ayub Med Coll Abbottabad. 2010;22(4):223.

    PubMed  Google Scholar 

  56. Ramchander V, Cameron ES, Reid HF. Lindane toxicity in an infant. West Indian Med J. 1991;40(1):41–3.

    CAS  PubMed  Google Scholar 

  57. Ginsburg CM, Lowry W, Reisch JS. Absorption of lindane (gamma benzene hexachloride) in infants and children. J Pediatr. 1977;91(6):998–1000.

    Article  CAS  PubMed  Google Scholar 

  58. Matsuoka LY. Convulsions following application of gamma benzene hexachloride. J Am Acad Dermatol. 1981;5(1):98–9.

    Article  CAS  PubMed  Google Scholar 

  59. Pramanik AK, Hansen RC. Transcutaneous gamma benzene hexachloride absorption and toxicity in infants and children. Arch Dermatol. 1979;115(10):1224–5.

    Article  CAS  PubMed  Google Scholar 

  60. Sadaka Y, Broides A, Tzion RL, Lifshitz M. Organophosphate acetylcholine esterase inhibitor poisoning from a home-made shampoo. J Emerg Trauma Shock. 2011;4(3):433–4.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Ramu A, Slonim AE, London M, Eyal F. Hyperglycemia in acute malathion poisoning. Isr J Med Sci. 1973;9(5):631–4.

    CAS  PubMed  Google Scholar 

  62. Hammond K, Leikin JB. Topical pyrethrin toxicity leading to acute-onset stuttering in a toddler. Am J Ther. 2008;15(4):323–4.

    Article  PubMed  Google Scholar 

  63. Uc A, Bishop WP, Sanders KD. Camphor hepatotoxicity. South Med J. 2000;93(6):596–8.

    Article  CAS  PubMed  Google Scholar 

  64. Skoglund RR, Ware LL Jr, Schanberger JE. Prolonged seizures due to contact and inhalation exposure to camphor. A case report. Clin Pediatr (Phila). 1977;16(10):901–2.

    Article  CAS  Google Scholar 

  65. Khine H, Weiss D, Graber N, Hoffman RS, Esteban-Cruciani N, Avner JR. A cluster of children with seizures caused by camphor poisoning. Pediatrics. 2009;123(5):1269–72.

    Article  PubMed  Google Scholar 

  66. Guilbert J, Flamant C, Hallalel F, Doummar D, Frata A, Renolleau S. Anti-flatulence treatment and status epilepticus: a case of camphor intoxication. Emerg Med J. 2007;24(12):859–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Joly C, Bouillie C, Hummel M. Acute poisoning by camphor administered externally in an infant. Ann Pediatr (Paris). 1980;27(6):395–6.

    CAS  PubMed  Google Scholar 

  68. Kauffman RBW. Camphor revisited: focus on toxicity. Committee on Drugs. American Academy of Pediatrics. Pediatrics. 1994;94(1):127–8.

    Google Scholar 

  69. Attof R, Magnin C, Bertin-Maghit M, Olivier L, Tissot S, Petit P. Methemoglobinemia by cerium nitrate poisoning. Burns. 2006;32(8):1060–1.

    Article  PubMed  Google Scholar 

  70. Lockhart JD, Simmons HE. Hexachlorophene decisions at the FDA. Pediatrics. 1973;51(2):430–4.

    CAS  PubMed  Google Scholar 

  71. US Food and Drug Administration. Sec. 250.250 Hexachlorophene, as a component of drug and cosmetic products. 1 April 2012. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=250.250. Accessed 23 June 2016.

  72. Martin-Bouyer G, Lebreton R, Toga M, Stolley PD, Lockhart J. Outbreak of accidental hexachlorophene poisoning in France. Lancet. 1982;1(8263):91–5.

    Article  CAS  PubMed  Google Scholar 

  73. Goutieres F, Aicardi J. Accidental percutaneous hexachlorophane intoxication in children. Br Med J. 1977;2(6088):663–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Chilcote R, Curley A, Loughlin HH, Jupin JA. Hexachlorophene storage in a burn patient associated with encephalopathy. Pediatrics. 1977;59(3):457–9.

    CAS  PubMed  Google Scholar 

  75. Curley A, Kimbrough RD, Hawk RE, Nathenson G, Finberg L. Dermal absorption of hexochlorophane in infants. Lancet. 1971;2(7719):296–7.

    Article  CAS  PubMed  Google Scholar 

  76. Shuman RM, Leech RW, Alvord EC Jr. Neurotoxicity of hexachlorophene in the human: I. A clinicopathologic study of 248 children. Pediatrics. 1974;54(6):689–95.

    CAS  PubMed  Google Scholar 

  77. Tyrala EE, Hillman LS, Hillman RE, Dodson WE. Clinical pharmacology of hexachlorophene in newborn infants. J Pediatr. 1977;91(3):481–6.

    Article  CAS  PubMed  Google Scholar 

  78. Powell H, Swarner O, Gluck L, Lampert P. Hexachlorophene myelinopathy in premature infants. J Pediatr. 1973;82(6):976–81.

    Article  CAS  PubMed  Google Scholar 

  79. Stanley-Brown EG, Frank JE. Mercury poisoning from application to omphalocele. JAMA. 1971;216(13):2144–5.

    Article  CAS  PubMed  Google Scholar 

  80. Clark JA, Kasselberg AG, Glick AD, O’Neill JA Jr. Mercury poisoning from merbromin (Mercurochrome) therapy of omphalocele: correlation of toxicologic, histologic, and electron microscopic findings. Clin Pediatr (Phila). 1982;21(7):445–7.

    Article  CAS  PubMed  Google Scholar 

  81. Beasley SW, Jones PG. Use of mercurochrome in the management of the large exomphalos. Aust Paediatr J. 1986;22(1):61–3.

    CAS  PubMed  Google Scholar 

  82. De Bont B, Lauwerys R, Govaerts H, Moulin D. Yellow mercuric oxide ointment and mercury intoxication. Eur J Pediatr. 1986;145(3):217–8.

    Article  PubMed  Google Scholar 

  83. Cunningham AA. Resorcin poisoning. Arch Dis Child. 1956;31(157):173–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Mosher JS, Lio P. Cytokine dermatitis and febrile seizure from imiquimod. Pediatrics. 2012;129(2):e519–22.

    Article  PubMed  Google Scholar 

  85. Mao XH, Wang JY, Yan JL. Topical imiquimod treatment of cutaneous vascular disorders in pediatric patients: clinical evaluation on the efficacy and safety. J Zhejiang Univ Sci B. 2012;13(9):745–50.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Campanelli A, Krischer J, Saurat JH. Topical application of imiquimod and associated fever in children. J Am Acad Dermatol. 2005;52(1):E1.

    Article  PubMed  Google Scholar 

  87. Myhre PE, Levy ML, Eichenfield LF, Kolb VB, Fielder SL, Meng TC. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of molluscum contagiosum in children. Pediatr Dermatol. 2008;25(1):88–95.

    Article  PubMed  Google Scholar 

  88. Slater GE, Rumack BH, Peterson RG. Podophyllin poisoning. Systemic toxicity following cutaneous application. Obstet Gynecol. 1978;52(1):94–6.

    CAS  PubMed  Google Scholar 

  89. Stoehr GP, Peterson AL, Taylor WJ. Systemic complications of local podophyllin therapy. Ann Intern Med. 1978;89(3):362–3.

    Article  CAS  PubMed  Google Scholar 

  90. Moher LM, Maurer SA. Podophyllum toxicity: case report and literature review. J Fam Pract. 1979;9(2):237–40.

    CAS  PubMed  Google Scholar 

  91. Conard PF, Hanna N, Rosenblum M, Gross JB. Delayed recognition of podophyllum toxicity in a patient receiving epidural morphine. Anesth Analg. 1990;71(2):191–3.

    Article  CAS  PubMed  Google Scholar 

  92. Vonweiss JF, Lever WF. Percutaneos salicylic acid intoxication in psoriasis. Arch Dermatol. 1964;90:614–9.

    Article  CAS  PubMed  Google Scholar 

  93. Oualha M, Dupic L, Bastian C, Bergounioux J, Bodemer C, Lesage F. Local salicylate transcutaneous absorption: an unrecognized risk of severe intoxication: a case report. Arch Pediatr. 2012;19(10):1089–92.

    Article  CAS  PubMed  Google Scholar 

  94. Abdel-Magid EH, el-Awad Ahmed FR. Salicylate intoxication in an infant with ichthyosis transmitted through skin ointment–a case report. Pediatrics. 1994;94(6 Pt 1):939–40.

  95. Germann R, Schindera I, Kuch M, Seitz U, Altmeyer S, Schindera F. Life threatening salicylate poisoning caused by percutaneous absorption in severe ichthyosis vulgaris. Hautarzt. 1996;47(8):624–7.

    Article  CAS  PubMed  Google Scholar 

  96. Galea P, Goel KM. Salicylate poisoning in dermatological treatment. Arch Dis Child. 1990;65(3):335.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Chiaretti A, Wismayer DS, Tortorolo L, Piastra M, Polidori G. Salicylate intoxication using a skin ointment. Acta Paediatr. 1997;86(3):330–1.

    Article  CAS  PubMed  Google Scholar 

  98. Yamamura S, Kinoshita Y, Kitamura N, Kawai S, Kobayashi Y. Neonatal salicylate poisoning during the treatment of a collodion baby. Clin Pediatr (Phila). 2002;41(6):451–2.

    Article  PubMed  Google Scholar 

  99. Loraschi A, Marelli R, Crema F, Lecchini S, Cosentino M. An unusual systemic reaction associated with topical salicylic acid in a paediatric patient. Br J Clin Pharmacol. 2008;66(1):152–3.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Broderick-Cantwell JJ. Case study: accidental clonidine patch overdose in attention-deficit/hyperactivity disorder patients. J Am Acad Child Adolesc Psychiatry. 1999;38(1):95–8.

    Article  CAS  PubMed  Google Scholar 

  101. Killian CA, Roberge RJ, Krenzelok EP, Stonage CL. “Cloniderm” toxicity: another manifestation of clonidine overdose. Pediatr Emerg Care. 1997;13(5):340–1.

    Article  CAS  PubMed  Google Scholar 

  102. Parekh D, Miller MA, Borys D, Patel PR, Levsky ME. Transdermal patch medication delivery systems and pediatric poisonings, 2002–2006. Clin Pediatr (Phila). 2008;47(7):659–63.

    Article  PubMed  Google Scholar 

  103. Sullivan RW, Ryzewski M, Holland MG, Marraffa JM. Compounded ointment results in severe toxicity in a pediatric patient. Pediatr Emerg Care. 2013;29(11):1220–2.

    Article  PubMed  Google Scholar 

  104. Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Giffin SL. 2008 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol (Phila). 2009;47(10):911–1084.

    Article  PubMed  Google Scholar 

  105. Bronstein AC, Spyker DA, Cantilena LR Jr, Green J, Rumack BH, Heard SE. 2006 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS). Clin Toxicol (Phila). 2007;45(8):815–917.

    Article  PubMed  Google Scholar 

  106. Watson WA, Litovitz TL, Rodgers GC Jr, Klein-Schwartz W, Youniss J, Rose SR, et al. 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2003;21(5):353–421.

    Article  PubMed  Google Scholar 

  107. Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Dart RC. 2010 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila). 2011;49(10):910–41.

    Article  PubMed  Google Scholar 

  108. Meyer D, Tobias JD. Adverse effects following the inadvertent administration of opioids to infants and children. Clin Pediatr (Phila). 2005;44(6):499–503.

    Article  PubMed  Google Scholar 

  109. Behrman A, Goertemoeller S. A sticky situation: toxicity of clonidine and fentanyl transdermal patches in pediatrics. J Emerg Nurs. 2007;33(3):290–3.

    Article  PubMed  Google Scholar 

  110. Lyttle MD, Verma S, Isaac R. Transdermal fentanyl in deliberate overdose in pediatrics. Pediatr Emerg Care. 2012;28(5):463–4.

    Article  PubMed  Google Scholar 

  111. Foy L, Seeyave DM, Bradin SA. Toxic leukoencephalopathy due to transdermal fentanyl overdose. Pediatr Emerg Care. 2011;27(9):854–6.

    Article  PubMed  Google Scholar 

  112. Woolf A, Burkhart K, Caraccio T, Litovitz T. Childhood poisoning involving transdermal nicotine patches. Pediatrics. 1997;99(5):E4.

    Article  CAS  PubMed  Google Scholar 

  113. Wain AA, Martin J. Can transdermal nicotine patch cause acute intoxication in a child? A case report and review of literature. Ulster Med J. 2004;73(1):65–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  114. Davies P, Levy S, Pahari A, Martinez D. Acute nicotine poisoning associated with a traditional remedy for eczema. Arch Dis Child. 2001;85(6):500–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Murphy NG, Albin C, Tai W, Benowitz NL. Anabasine toxicity from a topical folk remedy. Clin Pediatr (Phila). 2006;45(7):669–71.

    Article  PubMed  Google Scholar 

  116. Ducey J, Williams DB. Transcutaneous absorption of boric acid. J Pediatr. 1953;43(6):644–51.

    Article  CAS  PubMed  Google Scholar 

  117. Brooke C, Boggs T. Boric-acid poisoning; report of a case and review of the literature. AMA Am J Dis Child. 1951;82(4):465–72.

    CAS  PubMed  Google Scholar 

  118. Baker DH, Wilson RE. The lethality of boric acid in the treatment of burns. JAMA. 1963;186:1169–70.

    CAS  PubMed  Google Scholar 

  119. Goldbloom RB, Goldbloom A. Boric acid poisoning; report of four cases and a review of 109 cases from the world literature. J Pediatr. 1953;43(6):631–43.

    Article  CAS  PubMed  Google Scholar 

  120. Skipworth GB, Goldstein N, McBride WP. Boric acid intoxication from “medicated talcum powder”. Arch Dermatol. 1967;95(1):83–6.

    Article  CAS  PubMed  Google Scholar 

  121. Rubenstein AD, Musher DM. Epidemic boric acid poisoning simulating staphylococcal toxic epidermal necrolysis of the newborn infant: Ritter’s disease. J Pediatr. 1970;77(5):884–7.

    Article  CAS  PubMed  Google Scholar 

  122. Valdes-Dapena M, Arey J. Boric acid poisoning. Three fatal cases with pancreatic inclusions and a review of the literature. J Pediatr. 1962;61:531–46.

    Article  Google Scholar 

  123. Darben T, Cominos B, Lee CT. Topical eucalyptus oil poisoning. Australas J Dermatol. 1998;39(4):265–7.

    Article  CAS  PubMed  Google Scholar 

  124. Dreisinger N, Zane D, Etwaru K. A poisoning of topical importance. Pediatr Emerg Care. 2006;22(12):827–9.

    Article  PubMed  Google Scholar 

  125. Waldman N. Seizure caused by dermal application of over-the-counter eucalyptus oil head lice preparation. Clin Toxicol (Phila). 2011;49(8):750–1.

    Article  CAS  PubMed  Google Scholar 

  126. Yercen N, Caglayan S, Yucel N, Yaprak I, Ogun A, Unver A. Fatal hypernatremia in an infant due to salting of the skin. Am J Dis Child. 1993;147(7):716–7.

    CAS  PubMed  Google Scholar 

  127. Kaufman T, Monies-Chass I, Hirshowitz B, Bursztein S. Sodium poisoning: a lethal case of a burned child. Burns Incl Therm Inj. 1986;12(4):293–4.

    Article  CAS  PubMed  Google Scholar 

  128. Yiin LM, Tian JN, Hung CC. Assessment of dermal absorption of DEET-containing insect repellent and oxybenzone-containing sunscreen using human urinary metabolites. Environ Sci Pollut Res Int. 2015;22(9):7062–70.

    Article  CAS  PubMed  Google Scholar 

  129. Edwards DL, Johnson CE. Insect-repellent-induced toxic encephalopathy in a child. Clin Pharm. 1987;6(6):496–8.

    CAS  PubMed  Google Scholar 

  130. Briassoulis G, Narlioglou M, Hatzis T. Toxic encephalopathy associated with use of DEET insect repellents: a case analysis of its toxicity in children. Hum Exp Toxicol. 2001;20(1):8–14.

    Article  CAS  PubMed  Google Scholar 

  131. Roland EH, Jan JE, Rigg JM. Toxic encephalopathy in a child after brief exposure to insect repellents. Can Med Assoc J. 1985;132(2):155–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  132. Zadikoff CM. Toxic encephalopathy associated with use of insect repellant. J Pediatr. 1979;95(1):140–2.

    Article  CAS  PubMed  Google Scholar 

  133. Heick HM, Shipman RT, Norman MG, James W. Reye-like syndrome associated with use of insect repellent in a presumed heterozygote for ornithine carbamoyl transferase deficiency. J Pediatr. 1980;97(3):471–3.

    Article  CAS  PubMed  Google Scholar 

  134. Gryboski J, Weinstein D, Ordway NK. Toxic encephalopathy apparently related to the use of an insect repellent. N Engl J Med. 1961;264:289–91.

    Article  CAS  PubMed  Google Scholar 

  135. Centers for Disease Control (CDC). Seizures temporally associated with use of DEET insect repellent–New York and Connecticut. MMWR Morb Mortal Wkly Rep. 1989;38(39):678–80.

    Google Scholar 

  136. Lipscomb JW, Kramer JE, Leikin JB. Seizure following brief exposure to the insect repellent N,N-diethyl-m-toluamide. Ann Emerg Med. 1992;21(3):315–7.

    Article  CAS  PubMed  Google Scholar 

  137. Osimitz TG, Murphy JV, Fell LA, Page B. Adverse events associated with the use of insect repellents containing N, N-diethyl-m-toluamide (DEET). Regul Toxicol Pharmacol. 2010;56(1):93–9.

    Article  CAS  PubMed  Google Scholar 

  138. Raupp P, Hassan JA, Varughese M, Kristiansson B. Henna causes life threatening haemolysis in glucose-6-phosphate dehydrogenase deficiency. Arch Dis Child. 2001;85(5):411–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  139. Katar S, Devecioglu C, Ozbek MN, Ecer S. Henna causes life-threatening hyperbilirubinaemia in glucose-6-phosphate dehydrogenase deficiency. Clin Exp Dermatol. 2007;32(2):235–6.

    Article  CAS  PubMed  Google Scholar 

  140. Kok AN, Ertekin MV, Ertekin V, Avci B. Henna (Lawsonia inermis Linn.) induced haemolytic anaemia in siblings. Int J Clin Pract. 2004;58(5):530–2.

    Article  CAS  PubMed  Google Scholar 

  141. Devecioglu C, Katar S, Dogru O, Tas MA. Henna-induced hemolytic anemia and acute renal failure. Turk J Pediatr. 2001;43(1):65–6.

    CAS  PubMed  Google Scholar 

  142. Kandil HH, al-Ghanem MM, Sarwat MA, al-Thallab FS. Henna (Lawsonia inermis Linn.) inducing haemolysis among G6PD-deficient newborns. A new clinical observation. Ann Trop Paediatr. 1996;16(4):287–91.

  143. Curtis LA, Dolan TS, Seibert HE. Are one or two dangerous? Lidocaine and topical anesthetic exposures in children. J Emerg Med. 2009;37(1):32–9.

    Article  PubMed  Google Scholar 

  144. Copan L, Fowles J, Barreau T, McGee N. Mercury toxicity and contamination of households from the use of skin creams adulterated with mercurous chloride (Calomel). Int J Environ Res Public Health. 2015;12(9):10943–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  145. Khodashenas E, Aelami M, Balali-Mood M. Mercury poisoning in two 13-year-old twin sisters. J Res Med Sci. 2015;20(3):308–11.

    PubMed  PubMed Central  Google Scholar 

  146. Thompson TM, Toerne T, Erickson TB. Salicylate toxicity from genital exposure to a methylsalicylate-containing rubefacient. West J Emerg Med. 2016;17(2):181–3.

    Article  PubMed  PubMed Central  Google Scholar 

  147. Mauskar A, Karande S, Kulkarni M. Acquired methemoglobinemia due to contaminated colours: a preventable disaster. J Trop Pediatr. 2009;55(2):139–40.

    Article  PubMed  Google Scholar 

  148. Kagan BM, Mirman B, et al. Cyanosis in premature infants due to aniline dye intoxication. J Pediatr. 1949;34(5):574–8.

    Article  CAS  PubMed  Google Scholar 

  149. Majid Cheraghali A, Haghqoo S, Shalviri G, Shariati YR, Ghassemi M, Khosravi S. Fatalities following skin exposure to arsenic. Clin Toxicol (Phila). 2007;45(8):965–7.

    Article  CAS  PubMed  Google Scholar 

  150. Dawson JP, Thayer WW, Desforges JF. Acute hemolytic anemia in the newborn infant due to naphthalene poisoning: report of two cases, with investigations into the mechanism of the disease. Blood. 1958;13(12):1113–25.

    CAS  PubMed  Google Scholar 

  151. Schafer WB. Acute hemolytic anemia related to naphthalene; report of a case in a newborn infant. Pediatrics. 1951;7(2):172–4.

    CAS  PubMed  Google Scholar 

  152. Robson AM, Kissane JM, Elvick NH, Pundavela L. Pentachlorophenol poisoning in a nursery for newborn infants. I. Clinical features and treatment. J Pediatr. 1969;75(2):309–16.

    Article  CAS  PubMed  Google Scholar 

  153. Armstrong RW, Eichner ER, Klein DE, Barthel WF, Bennett JV, Jonsson V, et al. Pentachlorophenol poisoning in a nursery for newborn infants. II. Epidemiologic and toxicologic studies. J Pediatr. 1969;75(2):317–25.

    Article  CAS  PubMed  Google Scholar 

  154. Martin-Bouyer G, Khanh NB, Linh PD, Hoa DQ, Tuan LC, Tourneau J, et al. Epidemic of haemorrhagic disease in Vietnamese infants caused by warfarin-contaminated talcs. Lancet. 1983;1(8318):230–2.

    Article  CAS  PubMed  Google Scholar 

  155. Ramirez ME, Youseef WF, Romero RG, Martinez JM, Gonzalez-Ensenat MA, Vilaplana XS, et al. Acute percutaneous lactic acid poisoning in a child. Pediatr Dermatol. 2006;23(3):282–5.

    Article  PubMed  Google Scholar 

  156. Allen A, Siegfried E, Silverman R, Williams ML, Elias PM, Szabo SK, et al. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol. 2001;137(6):747–50.

    CAS  PubMed  Google Scholar 

  157. Prot-Labarthe S, Therrien R, Champagne MA, Duval M, Joubert C. Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease. Bone Marrow Transplant. 2007;40(3):295–6.

    Article  CAS  PubMed  Google Scholar 

  158. Shah KN, Yan AC. Low but detectable serum levels of tacrolimus seen with the use of very dilute, extemporaneously compounded formulations of tacrolimus ointment in the treatment of patients with netherton syndrome. Arch Dermatol. 2006;142(10):1362–3.

    Article  PubMed  Google Scholar 

  159. Allen DM, Esterly NB. Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis. Arch Dermatol. 2002;138(9):1259–60.

    Article  PubMed  Google Scholar 

  160. Neuman DL, Farrar JE, Moresi JM, Vogelsang GB, Higman MA. Toxic absorption of tacrolimus [corrected] in a patient with severe acute graft-versus-host disease. Bone Marrow Transplant. 2005;36(10):919–20.

    Article  CAS  PubMed  Google Scholar 

  161. Goluboff N, Macfadyen DJ. Methemoglobinemia in an infant, associated with application of a tar-benzocaine ointment. J Pediatr. 1955;47(2):222–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dennis P. West.

Ethics declarations

Conflict of interest

A Cices, S. Bayers, A.E. Verzì, L.A. Schachner, D.P. West, and G. Micali have no conflicts of interest that are directly relevant to the content of this review.

Funding

No sources of funding were used to prepare this review.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cices, A., Bayers, S., Verzì, A.E. et al. Poisoning Through Pediatric Skin: Cases from the Literature. Am J Clin Dermatol 18, 391–403 (2017). https://doi.org/10.1007/s40257-017-0252-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-017-0252-6

Keywords

Navigation